NMX-01

Multi-Compound Cognitive Research Formulation

A multi-component formulation containing six chemically distinct compounds of interest in neurochemical, cognitive, cholinergic, racetam-derivative, and central nervous system research.

Composition — Per Capsule

Citicoline (CDP-Choline) — 200 mg

CAS: 987-78-0

Molecular Formula: C₁₄H₂₆N₄O₁₁P₂

Molecular Weight: 488.32 g/mol

PubChem CID: 13804

Citicoline, also known as cytidine diphosphate-choline or CDP-choline, is an endogenous intermediate involved in phosphatidylcholine biosynthesis. It is of research interest because of its relationship to cellular phospholipid metabolism and its role as a source of choline.

---

L-Theanine — 100 mg

CAS: 3081-61-6

Molecular Formula: C₇H₁₄N₂O₃

Molecular Weight: 174.20 g/mol

PubChem CID: 439378

L-Theanine is a naturally occurring, non-proteinogenic amino acid associated primarily with Camellia sinensis. Research involving L-theanine has examined its neurochemical properties and interactions with CNS signaling systems.

---

Phenylpiracetam Hydrazide — 100 mg

CAS: 77472-71-0

Molecular Formula: C₁₂H₁₅N₃O₂

Molecular Weight: 233.27 g/mol

PubChem CID: 4995664

Also Known As: Fonturacetam Hydrazide

Phenylpiracetam Hydrazide is a structural derivative of phenylpiracetam in which the parent compound's amide functionality is replaced by a hydrazide group. The compound was reported in Russian chemical research examining substituted pyrrolidinone derivatives and remains primarily of experimental research interest.

---

Noopept (Omberacetam / GVS-111) — 30 mg

CAS: 157115-85-0

Molecular Formula: C₁₇H₂₂N₂O₄

Molecular Weight: 318.37 g/mol

PubChem CID: 180496

Noopept, also known as omberacetam or GVS-111, is N-phenylacetyl-L-prolylglycine ethyl ester. It is a synthetic small molecule investigated in neuropharmacological research and is structurally distinct from traditional racetams despite frequently being discussed alongside that class.

---

FLModafinil — 25 mg

CAS: 90280-13-0

Molecular Formula: C₁₅H₁₃F₂NO₂S

Also Known As: CRL-40,941, Bisfluoromodafinil, NLS-4

FLModafinil is a fluorinated structural analogue related to modafinil. Its molecular structure incorporates two para-fluoro substitutions on the diphenyl portion of the molecule. It has been investigated experimentally in CNS and wakefulness-related pharmacological research.

---

PRL-8-53 — 10 mg

CAS: 51352-87-5*

Molecular Formula: C₁₈H₂₂ClNO₂*

Molecular Weight: 319.83 g/mol*

PRL-8-53 is a synthetic substituted benzoate derivative first described in the 1970s. Historical experimental work investigated its CNS activity and potential interactions with dopaminergic, serotonergic and cholinergic systems. Published human research is extremely limited, with the best-known study dating to 1978.

*Specifications shown correspond to the hydrochloride form associated with CAS 51352-87-5.

Research Profile

The formulation combines compounds representing several structurally and mechanistically distinct areas of experimental interest, including:

• Choline and phospholipid metabolism

• Cholinergic signaling research

• Amino-acid-related CNS research

• Racetam and pyrrolidinone derivative research

• Experimental neurochemical signaling

• Dopaminergic and monoaminergic research

• Learning and memory research models

• Wakefulness-related CNS research

These areas describe fields in which the individual compounds have been studied and should not be interpreted as established effects of the combined formulation.

Product Specifications

Quantity: 30 Capsules

Total Active Material: 465 mg per capsule

Format: Multi-Compound Research Formulation

Research Notice

This product contains experimental compounds for which the available scientific evidence varies substantially. Inclusion of a compound does not establish clinical efficacy, safety, or suitability for therapeutic use.

FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION.

Not intended to diagnose, treat, cure, or prevent any disease.